Conference abstract · 20 Jun 2016
Conference abstractPublished 20 Jun 2016
CSIRs cutting edge tools and platform technologies that accelerate drug discovery R&D
Council for Scientific and Industrial Research, South Africa
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The long time-lines and high cost of drug discovery and development ensues. With this context, pharmaceutical companies are exploring more active partnership models with academia and Biotech companies. The high genetic variability of the African population, resulting in some of these drugs not being effective in African population and resulting in adverse toxic effects not experienced in other population groups remains critical in the African context. The CSIR has developed a number of cutting edge tools that address the factors. The first is a high throughput array printing technology that enables screening of 3000 compounds per week versus 300 per week using some of the current technologies. Through this proprietary technology, the pharmaceutical companies can time and cost efficiently, be able to screen their compounds for specific bioactivity. Secondly through our synthetic biology platform, CSIR can utilize genetic engineering tools for dry repurposing as well as screening against specific genetic backgrounds using stem cells technologies. Thirdly, CSIR’s capability in high throughput screening enables it to screen specific drugs at a high throughput against markers known to result in varied drug metabolism, resulting in toxicity. Lastly, the nanotechnology encapsulation and re-formulation platform, addresses specific limitations of bio and pharmaceutically active molecules. These technologies can improve the solubility, delay and control the release of actives as well as facilitate intracellular drug delivery and target to the site of interest. CSIR, in partnership with academic institutions is well positioned to develop tools that will result in realization of precision medicine objectives, cost and time effective screening tools, drug repurposing efforts and implement reformulated products.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 28 Jun 2024
Innovative Drug Discovery Platforms: Accelerating the Path from Bench to Bedside
Review article · 20 Jan 2009
Genetic Markers - A Cutting-Edge Technology in Herbal Drug Research
Article · 27 Dec 2023
Phage Display Technology as a Powerful Platform for Antibody Drug Discovery
Conference abstract · 14 May 2018
Novel antibacterial series identified through integrated drug discovery technology platform
More from this journal
The newest in Journal of Pharmaceutical Care & Health Systems.
Review article · 9 Jun 2025
Blood Fluid: The Unseen Currents That Bind Life and Death Together
Research article · 8 Jun 2025
Formulation and Antibacterial Evaluation of Acmella olaracea (Akarkara) Gummies Used for Toothache
Research article · 9 Apr 2025
Deep Vein Thrombosis: A Closer Look at a Silent Threat
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Care & Health Systems
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Boitumelo Semete-Makokotlela”

